CRISPR-Cas13 technique targets proteins causing ALS and Huntington’s disease in the mouse nervous system
Imaging collagen: A new technique for therapeutics?
19 January 2022Artificial pancreas proves ‘life-changing’ for very young children with type 1 diabetes and their families
19 January 2022CRISPR-Cas13 technique targets proteins causing ALS and Huntington’s disease in the mouse nervous system
A single genetic mutation can have profound consequences, as demonstrated in neurodegenerative diseases such as amyotrophic lateral sclerosis or Huntington’s disease. A new study by University of Illinois Urbana-Champaign researchers used a targeted CRISPR technique in the central nervous systems of mice to turn off production of mutant proteins that can cause ALS and Huntington’s disease.
